Well-established life sciences provider, approximately 6 million EUR in revenue, debt-free

The company offers a broad portfolio of reagents, laboratory equipment, and ready-to-use kits for applications in molecular and cell biology as well as related life sciences fields. The product range includes both selected brand-name products and custom-developed and manufactured solutions in the ODM/OEM business. The offering is complemented by the company’s own products, manufactured in Germany, with a focus on reliable quality, application-oriented functionality, and reproducible results. There is particular potential for innovation in the further development of solutions for modern proteomics applications and regulated markets.

The company serves exclusively B2B customers, including research and diagnostic laboratories, biotechnology and pharmaceutical companies, academic institutions, and international distributors. Depending on their needs, these customer groups purchase reagents, laboratory equipment, and kits for applications in molecular and cell biology. An internationally diversified customer base with long-standing business relationships ensures recurring revenue and a broad geographic presence. Customers particularly value the reliable product availability, scientific consulting, and the combination of established brand-name products and customized solutions.

The company operates in the global market for life science research products: reagents, kits, consumables, and laboratory equipment for molecular and cell biology. The market is international and technology-driven. It is dominated by a few very large corporations, but offers good opportunities for specialized medium-sized providers with a service and technology edge.

The core market is the German-speaking region, where the company operates its own sales force. In Western Europe, the company works with a combination of dealers and its own in-house sales team; internationally, it operates through approximately 70 distributors in 65 countries.

Growth opportunities: North America currently accounts for only about 10% of revenue, and a targeted expansion is planned. The Asia-Pacific region is being expanded with a small in-house team, while Latin America, India, and Africa are being newly developed.

In addition, the customer mix is shifting from the academic sector toward industry, pharmaceuticals, and diagnostics, where higher-priced devices are easier to sell. The expansion into proteomics and the pursuit of approval for the bioprocess market open up two additional growth segments.

The company competes with specialized suppliers of reagents, laboratory equipment, and kits for molecular and cell biology, as well as with larger international life sciences corporations and regional distributors. Indirect competition arises from alternative technologies, customer-specific in-house developments, and the direct purchase of comparable products through global online and specialty retail platforms. The company’s differentiated competitive position stems from a combination of exclusive distribution rights, international ODM/OEM expertise, and in-house production in Germany, complemented by an established distributor network and a long-standing market presence.